Medicare Enrolled

Dr. Amanda Nahhas, D.O.

Dermatology · Farmington Hills, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
28050 GRAND RIVER AVE, Farmington Hills, MI 48336
2484718224
In practice since 2015 (11 years)
NPI: 1104213917 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nahhas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nahhas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nahhas

Dr. Amanda Nahhas is a dermatology specialist in Farmington Hills, MI, with 11 years of NPI registration. Based on federal Medicare data, Dr. Nahhas performed 1,778 Medicare services across 869 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nahhas received a total of $7,616 from 31 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nahhas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 13% volume in MI $7,616 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,778
Medicare services
Top 13% in MI for dermatology
869
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
703 $4 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
220 $57 $141
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
200 $35 $153
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
128 $72 $209
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
104 $84 $208
Skin growth shaving, 0.5 cm or less
This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs.
82 $44 $222
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
75 $68 $253
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
66 $106 $320
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
64 $65 $276
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
28 $87 $324
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
24 $80 $315
Shaving of small skin growth on face or mouth area
A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth.
21 $61 $261
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
21 $208 $698
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
16 $80 $286
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
14 $49 $228
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals.
12 $77 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,616
Total received (2018-2024)
Avg $1,088/year across 7 years
Top 7% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,416 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,494
2023
$1,627
2022
$717
2021
$333
2020
$620
2019
$1,310
2018
$515

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$472
E.R. Squibb & Sons, L.L.C.
$378
Janssen Biotech, Inc.
$340
GENZYME CORPORATION
$256
Dermavant Sciences, Inc.
$160
Amgen Inc.
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Inari Medical, Inc.
$117
SANOFI-AVENTIS U.S. LLC
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$87
Novartis Pharmaceuticals Corporation
$82
Lilly USA, LLC
$80
PFIZER INC.
$49
Regeneron Healthcare Solutions, Inc.
$26
UCB, Inc.
$21
Arcutis Biotherapeutics, Inc.
$18
MERZ NORTH AMERICA, INC.
$17
Galderma Laboratories, L.P.
$15
Top 3 companies account for 47.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$828
GENZYME CORPORATION
$681
Sun Pharmaceutical Industries Inc.
$681
E.R. Squibb & Sons, L.L.C.
$678
AbbVie, Inc.
$599
Novartis Pharmaceuticals Corporation
$552
Janssen Biotech, Inc.
$537
Ortho Dermatologics, a division of Bausch Health US, LLC
$356
PFIZER INC.
$334
UCB, Inc.
$286
Amgen Inc.
$283
SUN PHARMACEUTICAL INDUSTRIES INC.
$268
Regeneron Healthcare Solutions, Inc.
$265
Lilly USA, LLC
$264
Dermavant Sciences, Inc.
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$180
Inari Medical, Inc.
$117
SANOFI-AVENTIS U.S. LLC
$100
LEO Pharma Inc.
$94
AbbVie Inc.
$88
Midmark Corporation
$45
Arcutis Biotherapeutics, Inc.
$32
Almirall LLC
$28
Incyte Corporation
$24
VYNE Pharmaceuticals Inc.
$23
Mayne Pharma Inc.
$22
MERZ NORTH AMERICA, INC.
$17
Galderma Laboratories, L.P.
$15
Smith+Nephew, Inc.
$13
Janssen Pharmaceuticals, Inc
$12
Biofrontera Inc.
$11
Top 3 companies account for 28.8% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · ALTRENO · AMELUZ · AMZEEQ · BRYHALI · Bimzelx · CIBINQO · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · EBGLYSS · EUCRISA · FLOWTRIEVER CATHETER · Humira · ILUMYA · Ilumya · LIBTAYO · LITFULO · OASIS MICRO · OPZELURA · Otezla · REMICADE · RINVOQ · S · SILIQ · SKYRIZI · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · XARELTO · Xeomin · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for dermatology in MI.

Looking for a dermatology specialist in Farmington Hills?
Compare dermatologists in the Farmington Hills area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
179
Per 100K population
14.1
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nahhas is a clinical cardiology specialist, with above-average Medicare volume (top 13% in MI), with low-engagement industry engagement in the top 7% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nahhas experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Nahhas performed 703 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nahhas receive payments from pharmaceutical companies?
Yes. Dr. Nahhas received a total of $7,616 from 31 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nahhas's costs compare to other dermatologists in Farmington Hills?
Dr. Nahhas's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nahhas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →